Risk Factors at Chronic Non-communicable Diseases in People of Working Age
FORTUNE
1 other identifier
observational
2,000
1 country
1
Brief Summary
Objectives: to study the clinical and demographic characteristics of working age persons, to highlight the main factors of non-communicable diseases (NCDs), to identify NCDs with physical examination, laboratory tests, electrocardiography and ultrasound imaging, to develop a corporate prevention program for the company to reduce the risk of complications of NCDs. Research stages:
- 1.Questionnaire to identify socio-demographic, behavioral, hereditary, psycho-emotional risk factors of NCDs
- 2.Laboratory tests (analysis of glucose and cholesterol in the capillary blood, detection of microalbuminuria), diagnostic tests (electrocardiography, and carotid artery ultrasound)
- 3.Evaluation of the results of questionnaires and surveys. Recommendations for lifestyle modification and follow-up in a local healthcare department
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 1, 2025
CompletedFirst Posted
Study publicly available on registry
February 6, 2025
CompletedStudy Start
First participant enrolled
April 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2026
CompletedFebruary 6, 2025
February 1, 2025
1 year
February 1, 2025
February 1, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
prevalence of NCDs risk factors
risk factors of NCDs based on survey results and diagnostic tests
on enrollment
prevalence of NCDs
diagnosed NCDs based on survey results, and diagnostic tests
on enrollment
Secondary Outcomes (1)
Hospitalization
on enrollment
Study Arms (1)
Persons without NCDs
Persons without known NCDs and not using any medication on a permanent basis
Interventions
express test
Ultrasound examination with Lumify Handheld S4-1 Phased Array Ultrasound (Philips)
Ultrasound examination with Lumify Handheld L12-4 Linear Array Ultrasound (Philips)
Eligibility Criteria
The study is planned to include all working citizens who meet the inclusion criteria and have come for preventive examination. In total, at least 2,000 people are planned to be included in the study. All participants will be given informed consent to participate in the clinical trial
You may qualify if:
- employees of the company
- persons without NCDs diagnosis and not receiving permanent medication
- residents of the region of the Russian Federation where a factory with permanent or temporary registration is located
You may not qualify if:
- refusal to sign informed consent
- any NCDs requiring constant medication
- active cancer
- pulmonary embolism
- valve defects of the heart (except secondary mitral regurgitation)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Medical Research Center for Therapy and Preventive Medicine
Moscow, Russia
Biospecimen
blood and urine samples
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Olga Dzhioeva, MD, PhD
National Medical Research Center for Therapy and Preventive Medicine
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 1, 2025
First Posted
February 6, 2025
Study Start
April 1, 2025
Primary Completion
April 1, 2026
Study Completion
April 1, 2026
Last Updated
February 6, 2025
Record last verified: 2025-02